Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | HaemSTAR UK-wide “Flash-Mob” audit of IVIg use in ITP

Pip Nicolson • 2 Apr 2019
BSH 2019
Immune Thrombocytopenia Non-Malignant

HaemSTAR (Specialty Trainee Audit and Research) is a network of clinical hematology registrars within the UK that aim to promote clinical research in non-malignant hematology. Here, Pip Nicolson, MA, MB BChir (Cantab), MRCP (UK), University of Birmingham, Birmingham, UK, discusses the HaemSTAR-led, UK-wide “Flash-Mob” audit of intravenous immunoglobulin use in immune thrombocytopenia (ITP). This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

More from Pip Nicolson

1:19
HaemSTAR: promoting clinical research in non-malignant hematology
Pip Nicolson • 16 Apr 2018
1:23
Case study: acquired von Willebrand disease in allogeneic BMT
Pip Nicolson • 16 Apr 2018

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals